Q2 2026 saw strong contract awards and backlog growth, but reported revenue and net income declined due to portfolio-shaping actions and joint venture charges. Excluding these, adjusted EBITDA and margins improved, with robust performance in the Middle East and significant new contract wins.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.